Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
CareerCenter
Medical Coding Job Board
Log in Register free account

Need help choosing the right code?

Ask CasePilot about procedures, modifiers, bundling, and coding guidance.

Try CasePilot

Official Description

Infectious agent antigen detection by immunofluorescent technique; Chlamydia trachomatis

© Copyright 2026 American Medical Association. All rights reserved.

Common Language Description

The CPT® Code 87270 refers to the process of detecting the presence of the infectious agent Chlamydia trachomatis through an immunofluorescent technique. This procedure is crucial for identifying Chlamydia trachomatis, a bacterium responsible for a common sexually transmitted disease (STD). Often, this infection does not present noticeable symptoms, particularly in women, which can lead to severe complications such as irreversible damage to the reproductive system and potential infertility. In contrast, men may experience symptoms like burning and itching in the urethra, although they are less likely to suffer long-term reproductive issues from the infection. The immunofluorescent antigen detection method employed in this procedure utilizes a direct fluorescent antibody (DFA) technique. During the test, a specimen is collected from various anatomical sites, including genital, rectal, ocular, or nasopharyngeal swabs. Following specimen collection, a specific reagent for Chlamydia trachomatis is applied and incubated under controlled conditions to facilitate the antigen-antibody reaction. After incubation, the specimen undergoes a washing process to eliminate any unbound conjugate, followed by drying and mounting. The final examination is conducted using a fluorescence microscope equipped with the necessary light source and barrier filters, allowing for the visualization of antigen-antibody binding. A positive test result is indicated by the appearance of bright green or orange-yellow objects under the microscope, confirming the presence of Chlamydia trachomatis in the specimen.

© Copyright 2026 Coding Ahead. All rights reserved.

1. Indications

The procedure associated with CPT® Code 87270 is indicated for the detection of Chlamydia trachomatis in patients who may be at risk for this sexually transmitted infection. The following conditions warrant the use of this test:

  • Asymptomatic Screening Individuals who are asymptomatic but are at risk for Chlamydia trachomatis infection, particularly sexually active women under 25 years of age and men who have sex with men.
  • Symptomatic Patients Patients presenting with symptoms such as abnormal genital discharge, burning sensation during urination, or pelvic pain, which may suggest a Chlamydia infection.
  • Follow-Up Testing Individuals who have previously tested positive for Chlamydia trachomatis and require follow-up testing to confirm the resolution of the infection after treatment.
  • Pregnant Women Pregnant individuals who are at risk for Chlamydia trachomatis infection, as untreated infections can lead to complications such as preterm birth and neonatal infections.

2. Procedure

The procedure for CPT® Code 87270 involves several critical steps to ensure accurate detection of Chlamydia trachomatis. The following outlines the procedural steps:

  • Specimen Collection A specimen is collected from the patient using a swab. This swab can be taken from various anatomical sites, including the genital area, rectum, eyes, or nasopharynx, depending on the clinical scenario and the patient's symptoms.
  • Reagent Application After specimen collection, a specific reagent designed for Chlamydia trachomatis is applied to the specimen. This reagent contains antibodies that will bind to the Chlamydia antigens if present.
  • Incubation The specimen is then incubated for a period of 15 to 30 minutes at body temperature in a humid environment. This incubation period allows sufficient time for the antigen-antibody reaction to occur, facilitating the binding of the antibodies to any Chlamydia antigens present in the specimen.
  • Washing Following incubation, the specimen undergoes a washing process to remove any unbound conjugate. This step is crucial to ensure that only the bound antigen-antibody complexes remain for examination.
  • Drying and Mounting After washing, the specimen is dried and mounted onto a suitable slide for microscopic examination. Proper mounting is essential for clear visualization of the specimen under the microscope.
  • Microscopic Examination The final step involves examining the specimen using a fluorescence microscope equipped with the appropriate fluorescent light source and barrier filters. The presence of antigen-antibody binding is indicated by bright green or orange-yellow fluorescence, which confirms a positive test result for Chlamydia trachomatis.

3. Post-Procedure

After the completion of the immunofluorescent antigen detection procedure for Chlamydia trachomatis, the following post-procedure considerations are important:

Patients may be advised to await the results of the test, which can typically be provided within a short timeframe. If the test result is positive, appropriate treatment options should be discussed with the patient, including antibiotic therapy to eliminate the infection. It is also essential to inform the patient about the importance of notifying sexual partners to prevent further transmission of the infection. In cases of negative results, if symptoms persist or if there is a high suspicion of infection, further testing or alternative diagnostic methods may be warranted. Additionally, patients should be counseled on safe sexual practices to reduce the risk of future infections.

Short Descr CHLAMYDIA TRACHOMATIS AG IF
Medium Descr IAADI CHLAMYDIA TRACHOMATIS
Long Descr Infectious agent antigen detection by immunofluorescent technique; Chlamydia trachomatis
Status Code Statutory Exclusion (from MPFS, may be paid under other methodologies)
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 9 - Not Applicable
Multiple Procedures (51) 9 - Concept does not apply.
Bilateral Surgery (50) 9 - Concept does not apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 9 - Concept does not apply.
Co-Surgeons (62) 9 - Concept does not apply.
Team Surgery (66) 9 - Concept does not apply.
Diagnostic Imaging Family 99 - Concept Does Not Apply
CLIA Waived (QW) No
APC Status Indicator Conditionally packaged laboratory tests
Type of Service (TOS) 5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS) T1H - Lab tests - other (non-Medicare fee schedule)
MUE 1
CCS Clinical Classification 206 - Microscopic examination (bacterial smear, culture, toxicology)
90 Reference (outside) laboratory: when laboratory procedures are performed by a party other than the treating or reporting physician or other qualified health care professional, the procedure may be identified by adding modifier 90 to the usual procedure number.
Date
Action
Notes
2011-01-01 Changed Short description changed.
2001-01-01 Changed Code description changed.
1998-01-01 Added First appearance in code book in 1998.
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"